Covid New Variant 2022

Covid, FDA

FDA Panel Backs New COVID Vaccines Aimed at Dominant Strain

The Vaccines and Related Biological Products Advisory Committee (VRBPAC) also discussed the need to target the long-simmering BA.3.2 variant, also known as "cicada," though most expressed confidence that targeting XFG was the right way to go.

· 1d

FDA panel lays out new Covid vaccine formulation recommendation

Axios on MSN · 2d

FDA vaccine advisers recommend updating COVID shots

AOL

What To Know About "Cicada," the New Covid Variant

A variant of COVID-19 called BA.3.2, which has circulated under the radar since late 2024, is now spreading quickly across the United States. There’s no sign so far that BA.3.2, nicknamed Cicada, ...

NBC DFW

A new, highly mutated COVID variant called ‘Cicada' is spreading in the U.S. Know these symptoms

BA.3.2, a heavily mutated new COVID-19 variant which may be better able to escape immunity from vaccines or prior infection, is now spreading in the United States. Although COVID cases are ...

12d

New COVID-19 variants surging in Japan as cases begin to escalate

A new variant of the novel coronavirus called EG.5 is spreading in Japan, with experts expecting it to be the dominant strain ...

COVID-19 variant NB.1.8.1: Everything you need to know about the new dominant strain and how our vaccines will hold up

A new COVID-19 variant is drawing global attention due to its rapid spread worldwide. The variant — NB.1.8.1 — is set to ...

AstraZeneca sees higher 2022 sales even as COVID boost wanes

AstraZeneca raised its annual dividend for the first time in a decade on Thursday and forecast higher sales for 2022 as new ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results